United States · FDA National Drug Code directory
Allergy Relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 21130-712_38a06b8a-bd81-4696-e063-6294a90a1f38
- Product NDC
- 21130-712
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- BETTER LIVING BRANDS, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230531
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (21130-712-03) / 30 TABLET in 1 BOTTLE · 21130-712-03
- 1 BOTTLE in 1 CARTON (21130-712-12) / 120 TABLET in 1 BOTTLE · 21130-712-12
- 1 BLISTER PACK in 1 CARTON (21130-712-46) / 14 TABLET in 1 BLISTER PACK · 21130-712-46
- 1 BOTTLE in 1 CARTON (21130-712-58) / 45 TABLET in 1 BOTTLE · 21130-712-58
- 2 BOTTLE in 1 CARTON (21130-712-81) / 90 TABLET in 1 BOTTLE (21130-712-09) · 21130-712-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →